Platelet-based Therapy May Slow Lung Function Decline

Platelet-based Therapy May Slow Lung Function Decline

299026

Platelet-based Therapy May Slow Lung Function Decline

Treatment with PRP-PC, an investigational platelet-based cellular therapy, may slow the decline in lung function typically experienced by people with chronic obstructive pulmonary disease (COPD), a new study with real-world data indicates. With this therapy, being developed by H-CYTE, a person’s own blood is treated in the lab and then infused back into the patient, with a goal of lessening inflammation. The study’s findings provide “clinically significant real-world data … aimed at improving lung health,”…

You must be logged in to read/download the full post.